Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Further 16 items receive concessionary prices for February

The Department of Health and Social Care and the National Assembly for Wales have agreed further concessionary prices for the following 16 items for February 2018 prescriptions.

Drug
Strength
Form
Price
Anastrozole
1mg
tablets (28)
£3.72
Aripiprazole
5mg
tablets (28)
£4.90
Enalapril
10mg
tablets (28)
£1.98
Enalapril
20mg
tablets (28)
£2.16
Eplerenone
25mg
tablets (28)
£19.80
Fexofenadine
180mg
tablets (30)
£2.98
Glimepiride
3mg
tablets (30)
£5.28
Irbesartan
300mg
tablets (28)
£6.95
Irbesartan
75mg
tablets (28)
£3.01
Levetiracetam
100mg/ml
sugar-free oral solution (300ml)
£8.08
Pregabalin
225mg
capsules (56)
£5.57
Terbinafine
250mg
tablets (14)
£6.99
Tolterodine
1mg
tablets (56)
£3.80
Tolterodine
2mg
tablets (56)
£4.10
Venlafaxine
37.5mg
tablets (56)
£3.79
Venlafaxine
75mg
tablets (56)
£5.99

An initial 38 items received concessionary prices for February last week (February 23).

Do these prices reflect what you have paid in February so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD009195

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel